A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects

NCT01540864 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: HPP404
DRUG: Placebo

Sponsor

High Point Pharmaceuticals, LLC.